(Press-News.org) Recent studies have shown that the heart contains cardiac stem cells that can contribute to regeneration and healing during disease and aging. However, little is known about the molecules and pathways that regulate these cells. Now, a new study utilizing a heart failure model is providing insight into one way to coax the cardiac stem cells into repairing the damaged heart. The research, published by Cell Press in the August 2011 issue of the journal Cell Stem Cell, finds that low doses of erythropoietin (EPO), a hormone best known for controlling the production of red blood cells, might reduce the risk of heart failure associated with some anticancer therapies.
Chemotherapy with doxorubicin (DOX) has been used effectively to treat a broad range of cancers but is limited because of severe side effects, most notably heart failure. Likewise, blocking STAT3, an important factor that drives tumor growth has been associated with heart failure. To learn more about the activity of cardiac stem cells under these conditions, senior study author, Dr. Denise Hilfiker-Kleiner from the Medical School Hannover in Germany, and colleagues studied cardiac stem cells in mice that were lacking the STAT3 gene in their hearts or were treated with DOX.
Dr. Hilfiker-Kleiner and colleagues observed that in both groups of mice, cardiac stem cells displayed an impaired ability to form new blood vessels which are essential for oxygen delivery to the heart muscle. Both sets of mice produced less EPO in their heart muscle than untreated controls. The researchers went on to demonstrate that EPO binds to cardiac stem cells and is required to maintain the signaling molecules necessary for production of new blood vessels. Importantly, when the mice were given a synthetic EPO derivative at a low dose which did not affect red blood cell production, stem cell differentiation to blood vessel cells was restored and cardiac function was preserved. "Short-term EPO administration at low doses seems an attractive avenue to pursue for protecting the heart during chemotherapy and might have broader applications in cardiac regeneration," concludes Dr. Hilfiker-Kleiner.
### END
Hormone reduces risk of heart failure from chemotherapy
2011-08-06
ELSE PRESS RELEASES FROM THIS DATE:
Mutation linked with the absence of fingerprints
2011-08-06
Scientists have identified a mutation that might underlie an extremely rare condition, called "adermatoglyphia," which causes people to be born without any fingerprints. The research, published by Cell Press online August 4th in The American Journal of Human Genetics, not only provides valuable insight into the genetic basis of adermatoglyphia and of typical fingerprint formation but also underscores the usefulness of rare genetic mutations as a tool for investigating unknown aspects of our biology.
Human skin has ridges called dermatoglyphs that are present on the fingers, ...
Novel DNA-sensing pathway in immune response to malaria
2011-08-06
Until very recently, it was unclear why infection with malaria causes fever and, under severe circumstances, an infectious death. Although the parasite has an abundance of potentially toxic molecules, no one knew which ones were responsible for the inflammatory syndrome associated with disease. Now, a new study identifies a novel DNA-sensing mechanism that plays a role in the innate immune response to the parasite that causes malaria. The findings, published online August 4th by Cell Press in the journal Immunity, provide new insight into how the immune system detects ...
East Africa's climate under the spell of El Niño since the last Ice Age
2011-08-06
Floods and droughts in East Africa are often unleashed by far-away events in the tropical Pacific—the warm (El Niño) or cool (La Niña) phases of the El Niño-Southern Oscillation (ENSO). A catastrophic drought is currently wreaking havoc in wide regions of Kenya, Ethiopia, Djibouti and Somalia, affecting food security and putting millions of people in urgent need of assistance. Scientists have attributed the severe drying to La Niña conditions that prevailed from June 2010 to May 2011 in the Pacific.
The waxing and waning of rainfall in eastern tropical Africa in unison ...
David Blair, QuadCap Wealth Management, and Bond Ladders III
2011-08-06
Why Use a Ladder?
It's a Strategy for All Interest Rate Environments. Since a bond ladder enables you to reinvest your assets periodically over time, your portfolio will be less affected by interest rate volatility. This concept is similar to dollar cost averaging in stocks. As bonds come due, you are able to reinvest your principal into bonds of intermediate or longer term maturities, where the yields are higher.We started QuadCap Wealth Management, LLC to focus on a highly personalized comprehensive counseling program that is driven by dedicated personal service. ...
Genetic 'signature' discovered in plaque, possible key to future treatment
2011-08-06
Italian researchers may have identified a genetic "signature" for dangerous plaque that leads to stroke.
Reporting from their study published in Stroke: Journal of the American Heart Association, the researchers said a pattern of five microscopic bits of genetic material called microRNAs (miRNAs) — a genetic "signature" — were present only in the plaque from patients who had experienced a stroke.
This is the first report to suggest that miRNAs may provide an important clue about which plaque in artery walls is the most dangerous.
Plaque is made up of fat, cholesterol, ...
Large variations in Arctic sea ice
2011-08-06
For the last 10,000 years, summer sea ice in the Arctic Ocean has been far from constant. For several thousand years, there was much less sea ice in The Arctic Ocean – probably less than half of current amounts. This is indicated by new findings by the Danish National Research Foundation for Geogenetics at the University of Copenhagen. The results of the study will be published in the journal Science.
Sea ice comes and goes without leaving a record. For this reason, our knowledge about its variations and extent was limited before we had satellite surveillance or observations ...
Screening effort turns up multiple potential anti-malaria compounds
2011-08-06
Researchers at the NIH Chemical Genomics Center, administered by NHGRI, used robotic, ultra-high-throughput screening technology to test more than 2,800 chemical compounds for activity against 61 genetically diverse strains of lab-grown malaria parasites. They found 32 compounds that were highly effective at killing at least 45 of the 61 strains. Ten of these compounds had not previously been reported to have anti-malarial action, and seven were more active at lower concentrations than artemisinin, a widely used malaria drug. All the screened compounds are already registered ...
David Blair, QuadCap Wealth Management, and Bond Ladders II
2011-08-06
Another advantage of using the ladder strategy is that you can customize your ladder to suit your individual investment objectives, such as meeting future funding needs or fulfilling specific income requirements. Investment selection will also take into account such things as your tax liabilities, quality considerations and anticipated future changes in your financial situation.
Ladders are typically built using a variety of the following types of fixed income securities: U.S. Treasury and government agency securities, tax-exempt municipal bonds, corporate bonds, zero-coupon ...
Innate cells shown to form immunological 'memory' and protect against viral infection
2011-08-06
Researchers have demonstrated that cells of the innate immune system are capable of "memory", and of mounting rapid protection to an otherwise lethal dose of live vaccinia virus. The study, published in the Open Access journal PLoS Pathogens on August 4th, challenges previous thought that only B cells and T cells can store memory to ward off future infection. The finding, by researchers from Beth Israel Deaconess Medical Center, Harvard Medical School, and Hebrew University and Duke University, has potentially significant consequences for the design of future vaccines, ...
Elusive gene mutations found for malignant brain tumor
2011-08-06
DURHAM, N.C. -- A discovery by scientists at Duke University Medical Center and Johns Hopkins University could increase the chances for an effective combination of drug therapy to treat the second most common type of brain tumor.
For years scientists have been looking for the primary cancer genes involved in the development of oligodendrogliomas. Scientists knew the two chromosomes that held the probable mutations, but not the particular gene information.
Now scientists at Duke and Johns Hopkins have discovered the most likely genetic mutations that researchers have ...